Document is current
Any future updates will be listed below
-
Authors
Gonçalves, Emanuel
Thomas, Mark
Behan, Fiona M.
Picco, Gabriele
Pacini, Clare
Allen, Felicity
Vinceti, Alessandro
Sharma, Mamta
Jackson, David A.
Price, Stacey
Beaver, Charlotte M.
Dovey, Oliver
Parry-Smith, David
Iorio, Francesco
Parts, Leopold
Yusa, Kosuke
Garnett, Mathew J. https://orcid.org/0000-0002-2618-4237
-
Funding
Funding for this research was provided by:
Wellcome Trust (206194)
Open Targets
- License Information
-
More Information
Article History
Received: 8 May 2020
Accepted: 7 January 2021
First Online: 21 January 2021
Ethics approval and consent to participate
: Not applicable.
: M.G. has performed consultancy for Sanofi, receives research funding from AstraZeneca and GSK, and is co-founder of Mosaic Therapeutics. F.I. receives funding from Open Targets, a public-private initiative involving academia and industry, and performs consultancy for the joint CRUK - AstraZeneca Functional Genomics Centre. L.P. receives funding from Open Targets. All other authors declare no competing interests.
